11. L 11 Ketogenesis[1] (1)_edited

Fatty acid oxidation is a metabolic process that breaks down fatty acids for energy production.
Ketogenesis is the production of ketone bodies from fatty acids, particularly during periods of low carbohydrate availability (e.g., starvation).

Beta-Oxidation: The process by which fatty acids are oxidized to produce acetyl-CoA, NADH, and FADH2.
- Involves multiple steps including oxidation, hydration, and thiolytic cleavage.
- Can oxidize saturated, monounsaturated, and polyunsaturated fatty acids.
- Energy yield varies depending on the type of fatty acid.
Energy Yield of Fatty Acid Oxidation:
- For example, palmitic acid yields significant ATP via a series of reactions leading to the production of acetyl-CoA that enters the TCA cycle.
- Total ATP yield calculation should consider the amount of NADH and FADH2 produced during oxidation as well as the downstream ATP generation in the TCA cycle.
Alpha-Oxidation: Important for branched-chain fatty acids, leads to the breakdown of phytanic acid.
- Involves hydrolysis of the alpha carbon.

Controlled by hormonal mechanisms:
- Glucagon and Epinephrine: Stimulate lipolysis; increase fatty acid release into the bloodstream.
- Insulin: Promotes lipogenesis and inhibits lipolysis.
Substrates and end products of metabolism:
- Citrate stimulates fatty acid synthesis, while high levels of malonyl-CoA inhibit fatty acid transport into mitochondria, effectively limiting beta-oxidation.

Definition: The metabolic pathway that synthesizes ketone bodies as an alternative energy source.
- Occurs primarily in the liver, may also take place in other tissues in response to metabolic conditions.
- Regulated by insulin levels and overall metabolic state.
- Associated with conditions like starvation and diabetes mellitus when glucose availability is low.
Ketosis: A metabolic state where the body utilizes fatty acids as the primary energy source, leading to increased levels of ketone bodies.

Ketone bodies (e.g., beta-hydroxybutyrate, acetoacetate) serve as an energy source for various tissues, including skeletal muscle and the heart.
Not used by the liver due to the absence of the enzyme necessary for their conversion back to acetyl-CoA.

Carnitine Palmitoyltransferase (CPT) Deficiency: Impairs fatty acid oxidation, leading to energy deficiencies.
Acyl-CoA Dehydrogenase Deficiency: Leads to metabolic disorders due to the inability to oxidize long-chain fatty acids adequately.
Refsum Disease: Characterized by the inability to oxidize phytanic acid due to defective alpha-oxidation, leading to accumulation of toxic compounds and subsequent nerve damage.

Diabetes Symptoms: Hyperglycemia, glucosuria leading to dehydration due to osmotic diuresis.
Fatty Acid Oxidation Disorders: Result in hypoglycemia and inadequate energy production.

Lipolysis: Breakdown of triglycerides into glycerol and fatty acids.
Lipogenesis: Synthesis of triglycerides from fatty acids and glycerol.
Fatty Acid Degradation: Involves beta-oxidation, which can handle even and odd-chain fatty acids differently.
Medium and Long-Chain Fatty Acid Processing: Often varies in metabolic pathways due to the presence of enzymes such as acyl-CoA dehydrogenase and the necessity of transport carriers like carnitine.